CTC phenotype classifier identifies mCRPC patients with high genomic instability CTCs and predicts failure of Androgen Receptor signaling (AR Tx) and taxane systemic therapies.
CTC phenotype classifier identifies mCRPC patients with high genomic instability CTCs and predicts failure of Androgen Receptor signaling (AR Tx) and taxane systemic therapies.